Engineering Enzyme-Cleavable Oligonucleotides by Automated Solid-Phase Incorporation of Cathepsin B Sensitive Dipeptide Linkers (2022)
Attributed to:
New oligonucleotide analogues for therapeutic applications
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/anie.202114016
PubMed Identifier: 34953094
Publication URI: http://europepmc.org/abstract/MED/34953094
Type: Journal Article/Review
Parent Publication: Angewandte Chemie International Edition
Issue: 13
ISSN: 1433-7851